1. Home
  2. RITM vs BIO Comparison

RITM vs BIO Comparison

Compare RITM & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RITM
  • BIO
  • Stock Information
  • Founded
  • RITM 2011
  • BIO 1952
  • Country
  • RITM United States
  • BIO United States
  • Employees
  • RITM N/A
  • BIO N/A
  • Industry
  • RITM Real Estate Investment Trusts
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • RITM Real Estate
  • BIO Industrials
  • Exchange
  • RITM Nasdaq
  • BIO Nasdaq
  • Market Cap
  • RITM 5.8B
  • BIO 6.7B
  • IPO Year
  • RITM N/A
  • BIO N/A
  • Fundamental
  • Price
  • RITM $11.24
  • BIO $239.02
  • Analyst Decision
  • RITM Strong Buy
  • BIO Strong Buy
  • Analyst Count
  • RITM 10
  • BIO 4
  • Target Price
  • RITM $13.15
  • BIO $330.50
  • AVG Volume (30 Days)
  • RITM 5.0M
  • BIO 314.3K
  • Earning Date
  • RITM 04-25-2025
  • BIO 05-01-2025
  • Dividend Yield
  • RITM 8.90%
  • BIO N/A
  • EPS Growth
  • RITM N/A
  • BIO N/A
  • EPS
  • RITM 1.19
  • BIO N/A
  • Revenue
  • RITM $3,560,550,000.00
  • BIO $2,541,100,000.00
  • Revenue This Year
  • RITM N/A
  • BIO $0.84
  • Revenue Next Year
  • RITM $6.97
  • BIO $4.64
  • P/E Ratio
  • RITM $9.43
  • BIO N/A
  • Revenue Growth
  • RITM 10.49
  • BIO N/A
  • 52 Week Low
  • RITM $9.13
  • BIO $215.38
  • 52 Week High
  • RITM $12.20
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • RITM 57.76
  • BIO 47.23
  • Support Level
  • RITM $10.84
  • BIO $228.91
  • Resistance Level
  • RITM $11.39
  • BIO $243.75
  • Average True Range (ATR)
  • RITM 0.24
  • BIO 9.67
  • MACD
  • RITM 0.11
  • BIO 0.36
  • Stochastic Oscillator
  • RITM 86.47
  • BIO 32.51

About RITM Rithm Capital Corp.

Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company aims to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Its investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights) loans (including single-family rental), and consumer loans. Its operating segments are Origination and Servicing; Investment Portfolio; Residential Transitional Lending; and Asset Management.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: